Oracle markets Clinical One as a unified platform for data collection, randomization, and trial supply management that lets teams build and modify studies without deployments or downtime and manage integrations in one place. Official Oracle documentation details study-flow responsibilities across roles such as Study Designer, Study Manager, Clinical Supply Manager, and Site User, as well as the Digital Gateway component for CTMS, EDC, and supply integrations. This profile focuses on documented functions, workflow entries, configuration settings, and explicit limitations rather than evaluative claims. [3][2][1]
Data Collection and Analytics
Oracle's product page states that Clinical One Data Collection goes beyond electronic data capture by enabling data collection from any source and harmonizing it in one place. The same marketing material describes Clinical One Analytics as a tool for creating calculated data elements, exploring multiple data sets dynamically, organizing dashboards, and producing subject reports. These statements are vendor claims about intended capabilities rather than independently verified outcomes. [3]
The study flow map in the Sponsor and CRO User Guide outlines data-related tasks such as adding subjects, entering data, managing queries, and running reports. Site Users typically add subjects and enter data, while Sponsor Users monitor subjects, create queries, and manage study archives. Report features documented in the Reporting Guide include standard reports, data extracts, and Oracle CRF Submit archives, with an option to add custom fields to a Subject Events report based on study design version, visits, forms, and questions. [2][7]
Release notes for Clinical One Cloud Service 26.3 describe enhancements including API throttling for integration load balancing and Lab Forms support for importing Electronic Health Record lab data. These release-note entries indicate current product direction but do not establish performance benchmarks or field-proven results. [6]
Randomization and Trial Supply Management
Clinical One includes Randomization and Trial Supply Management, described in source documentation as RTSM. The product page positions RTSM alongside Data Collection and Analytics as components of the Clinical One platform. A WallabyPhenox customer story on the marketing page states that the organization used Clinical One RTSM in connection with FDA clearance for a thrombectomy device; this is a vendor-presented customer claim. [3]
Release 26.3 documentation records two supply workflows: dispensation rollback limited to the latest dispensation visit, and combination kit dosing, which lets clinical supply managers create multiple dosages by combining different kit types after setting Automated Combination Kit Dosing to No under Supply Settings. The Reporting Guide documents supply fields including shipment ID prefix, dispensation methods, replacement details, and dose hold records. [6][7]
The study flow documentation assigns supply setup and conduct tasks to the Clinical Supply Manager role, including adding depots, creating resupply strategies, managing shipments, and handling kits at site and study level. Site Users receive shipments and dispense kits to subjects. These role mappings reflect documented default workflows that may vary by implementation configuration. [2]
Testing an Outbound Subject Data Flow
A hypothetical demonstration could show how a site user completes screening questions tagged as Required for Screening, triggering the Screen button and sending screening event data to a connected third-party EDC system according to configured integration settings. The scenario would deliberately avoid data flags, reflecting the documented limitation. This demonstration is illustrative only and does not indicate expected performance in any production environment.
For teams evaluating Clinical One, several implementation unknowns remain. Oracle documentation does not include standardized pricing, formal customer satisfaction ratings, or independently validated clinical efficacy data. Security certification status and full regulatory compliance evidence are not stated in the cited sources. Organizations should request current configuration-service details and study-specific integration limits from Oracle rather than infer them from documentation alone. [5][1]
Digital Gateway and Third-Party Integrations
Clinical One Digital Gateway provides an interface to create, configure, customize, monitor, and manage integrations. The Digital Gateway User Guide documents CTMS integration types including Study Version Template, Site, Subject Visit, and Source Data Verification integrations. The Site integration runs on a schedule and performs one-way data flow from CTMS into Clinical One Cloud Service. [1][3]
Documented third-party integration targets include global depot networks such as Almac, Fisher Clinical Services, and Catalent Clinical Supply Services for shipment status updates; Oracle Life Sciences InForm for data collection and study management; SmartSupplies PMD for kit tracking; and clinical trial management systems including Veeva Vault CTMS and Oracle Siebel CTMS. A documented limitation states that the SVT integration does not recognize Advanced Study Version changes applied to previous study versions and does not send them to CTMS. [4][1]
Outbound subject data integration sends subject event data from Clinical One Cloud Service to a third-party EDC system based on configuration settings. A configuration service detail lists Oracle Life Sciences Clinical One Digital Gateway Configuration Service at up to 70 Data Points. Documented limitations include a restriction against applying data flags in certain integration scenarios and lack of support for unscheduled visit mapping in rescreen data. [5]
Organizational Workflow and Study Setup
The study flow documentation distinguishes between global roles and study-level roles. Delegated administrators provision product roles in Oracle Life Sciences Identity and Access Management Service, while Product Administrators can act as Study Creators or Global User Managers. Study verification tasks require adding subjects, collecting data, managing kits and shipments, and running reports. [2]
Study configuration proceeds through Testing mode first, followed by Production and Training modes. In Testing mode, users verify that study settings match protocol requirements before making a study version available in Production. Source Data Verification strategy creation is assigned to the Study Manager role, while supply settings including resupply strategy are managed by the Clinical Supply Manager. [2]
The Reporting Guide identifies tenant-level reports including the Global Study Roles report, the Life Sciences Learn Training Report, the Study Roles report by study, and the User Assignment Across Studies report. Documentation also references a specification aid that may replace historically created study synopses in some organizations, although this is presented as a possible time-saving use rather than a guaranteed outcome. [7]
Integration Boundaries and Documented Gaps
Multiple limitations are explicitly documented. Outbound subject data integration restricts certain data flag uses. Screening data integration requires either visit completion or completion of questions tagged as Required for Screening depending on configuration. Non-serialized kit inventory data sent to a third-party EDC system requires contacting an Oracle point of contact. Cyclic visits and unscheduled visits in downstream systems are handled with specified constraints. [5]
Version boundaries also matter. The Digital Gateway User Guide is dated November 2026 with document part G58970-02 following an August 2026 original version; the Release Notes cover release 26.3.0.1. Features documented in one release or document version may differ from capabilities in other environments. Official sources do not provide an exhaustive taxonomy of all product modules, and absence of a feature in cited documentation should not be read as confirmed unavailability. [1][6]